Awardee OrganizationICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
Description
Abstract Text
The aims of this project are to apply genomic approaches to delineate mechanisms underlying the development of HIV associated nephropathy (HIVAN), one of the most common causes of renal failure. Using HIV-1 transgenic mice (TgFVB), we have already identified one QTL mediating severity of renal disease on mouse chromosome 3. We propose to identify this QTL and other QTL's controlling the development of renal disease through analysis of congenic strains and additional mapping cohorts, using a combination meiotic mapping, haplotype resolution, gene expression studies and sequence data mining. The specific aims of this project are: 1. Identify the QTL on mouse chromosome 3, A1-A3 (HIVAN1) underlying susceptibility to renal failure by generating additional mapping cohorts and congenic strains trapping this QTL, followed by detailed analysis of the meiotic interval, haplotypes structure and sequence. These analyses will be complemented by whole kidney gene expression studies in specific aim 2.
2. Perform gene expression analysis of the HIV-1 transgenic mice with contrasting susceptibility to HIV associated nephropathy (TgFVB, F1 hybrids and congenic strains) to obtain molecular
characterization of renal disease and identify gene expression phenotypes that correlate with renal disease in this model. Differentially expressed genes will also help prioritize positional candidates mapped by linkage analysis. 3. Perform a genome wide analysis of linkage to identify additional QTLs controlling gene expression and renal disease in HIVAN in two backcross cohort of (TgFVB X BALB) X TgFVB and (TgFVB X B6) X TgFVB mice. Linkage the same interval in multiple crosses will be complementary as they may identify common shared haplotypes that will assist in QTL identification. We will next use SNP genotyping, computational and bioinformatics tools to synthesize the data from the above studies in order to identify gene(s) underlying nephropathy and HIV mediated renal injury.
National Institute of Diabetes and Digestive and Kidney Diseases
CFDA Code
DUNS Number
078861598
UEI
C8H9CNG1VBD9
Project Start Date
01-July-2004
Project End Date
30-June-2009
Budget Start Date
01-July-2004
Budget End Date
30-June-2005
Project Funding Information for 2004
Total Funding
$212,399
Direct Costs
$212,399
Indirect Costs
Year
Funding IC
FY Total Cost by IC
2004
National Institute of Diabetes and Digestive and Kidney Diseases
$212,399
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 2P01DK056492-06 0001
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 2P01DK056492-06 0001
Patents
No Patents information available for 2P01DK056492-06 0001
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 2P01DK056492-06 0001
Clinical Studies
No Clinical Studies information available for 2P01DK056492-06 0001
News and More
Related News Releases
No news release information available for 2P01DK056492-06 0001
History
No Historical information available for 2P01DK056492-06 0001
Similar Projects
No Similar Projects information available for 2P01DK056492-06 0001